Erlotinib added to carboplatin and paclitaxel as first-line treatment of ovarian cancer: A phase II study based on surgical reassessment
Article
Blank, Stephanie V, Christos, Paul, Curtin, John P et al. (2010). Erlotinib added to carboplatin and paclitaxel as first-line treatment of ovarian cancer: A phase II study based on surgical reassessment
. GYNECOLOGIC ONCOLOGY, 119(3), 451-456. 10.1016/j.ygyno.2010.08.008
Blank, Stephanie V, Christos, Paul, Curtin, John P et al. (2010). Erlotinib added to carboplatin and paclitaxel as first-line treatment of ovarian cancer: A phase II study based on surgical reassessment
. GYNECOLOGIC ONCOLOGY, 119(3), 451-456. 10.1016/j.ygyno.2010.08.008